Get 20% lifetime commission for referring investors to digrin.com
here.
MacroGenics, Inc. ( MGNX) - Stock Earnings
MGNX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
MGNX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -14.2 million USD | 41.2 million USD |
| 2026Q1 | -36.8 million USD | 20.8 million USD |
| 2026Q2 | 19.5 million USD | 32.8 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MGNX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.1 million USD | 57.2 million USD |
| 2024 | -67.0 million USD | 148.3 million USD |
| 2025 | -74.6 million USD | 149.5 million USD |
| 2026 Est. | — | — |
MGNX
Price: $3.25
52 week price:
Earnings Per Share: -1.64 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 382181
Ebitda: -45.8 millionMarket Capitalization: 226.0 million